Tech Company Financing Transactions
Myosin Therapeutics Funding Round
DeepWork Capital, Florida Opportunity Fund and Mint12 Pharma invested in a Seed funding round for Myosin Therapeutics. The round was announced on 3/14/2023.
Transaction Overview
Company Name
Announced On
3/14/2023
Transaction Type
Amount
Unknown
Round
Seed
Proceeds Purpose
We are excited to receive this funding, which will allow us to rapidly advance our first-in-class treatments for glioblastoma and stimulant use disorder, two devastating conditions that lack effective treatments.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
130 Scripps Way
Jupiter, FL 33458
USA
Jupiter, FL 33458
USA
Phone
Undisclosed
Website
Email Address
Overview
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications targeting cellular motor proteins, specialized molecular machines that convert energy into mechanical work inside cells. Molecular motors are an under-exploited area of disease treatment, including cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Theodore Kamenecka
Co-Founder
Courtney Miller
Browse more venture capital transactions:
Prev: 3/14/2023: Awesomic venture capital transaction
Next: 3/14/2023: Upduo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs